IRIS
SONVICO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.925
AS - Asia 9.432
EU - Europa 6.445
SA - Sud America 1.230
Continente sconosciuto - Info sul continente non disponibili 447
AF - Africa 416
OC - Oceania 34
Totale 28.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.629
SG - Singapore 3.336
CN - Cina 2.531
VN - Vietnam 1.375
IT - Italia 1.317
IE - Irlanda 1.097
BR - Brasile 944
SE - Svezia 842
FI - Finlandia 738
HK - Hong Kong 675
DE - Germania 568
FR - Francia 480
BD - Bangladesh 426
UA - Ucraina 383
NL - Olanda 295
ZA - Sudafrica 290
TR - Turchia 272
GB - Regno Unito 199
IN - India 177
CA - Canada 167
RU - Federazione Russa 132
AR - Argentina 115
KR - Corea 90
AT - Austria 79
IQ - Iraq 75
MX - Messico 70
JP - Giappone 68
ID - Indonesia 67
ES - Italia 59
PL - Polonia 49
BE - Belgio 43
PK - Pakistan 40
CZ - Repubblica Ceca 38
TH - Thailandia 37
CO - Colombia 36
TW - Taiwan 35
EC - Ecuador 33
UZ - Uzbekistan 30
VE - Venezuela 30
PH - Filippine 28
PT - Portogallo 27
AU - Australia 26
MA - Marocco 24
PY - Paraguay 21
MY - Malesia 20
CL - Cile 19
DZ - Algeria 17
SA - Arabia Saudita 17
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
JO - Giordania 15
CR - Costa Rica 14
IR - Iran 14
LT - Lituania 14
CI - Costa d'Avorio 13
EU - Europa 13
KE - Kenya 13
RS - Serbia 13
IL - Israele 12
NP - Nepal 11
PE - Perù 11
AZ - Azerbaigian 10
BO - Bolivia 10
EG - Egitto 10
JM - Giamaica 10
KZ - Kazakistan 10
UY - Uruguay 10
AL - Albania 9
ET - Etiopia 9
LB - Libano 9
RO - Romania 9
HR - Croazia 8
NZ - Nuova Zelanda 8
HU - Ungheria 7
SY - Repubblica araba siriana 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
MD - Moldavia 6
SN - Senegal 6
BG - Bulgaria 5
GT - Guatemala 5
HN - Honduras 5
OM - Oman 5
GA - Gabon 4
PA - Panama 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
LV - Lettonia 3
NO - Norvegia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SC - Seychelles 3
BS - Bahamas 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
KW - Kuwait 2
KY - Cayman, isole 2
Totale 28.457
Salva come PNG Salva come JPEG
Città #
Singapore 1.635
Ashburn 1.306
Dublin 1.081
San Jose 980
Chandler 914
Santa Clara 822
Hong Kong 626
Beijing 602
Jacksonville 436
Dallas 419
Council Bluffs 410
Ho Chi Minh City 402
Parma 344
Dearborn 326
Ann Arbor 324
Boardman 293
Hanoi 280
Johannesburg 262
Los Angeles 226
Nanjing 224
New York 224
Lauterbourg 186
Izmir 185
Princeton 179
Shanghai 176
Hefei 145
Wilmington 123
Munich 116
Milan 111
Helsinki 104
Columbus 100
San Mateo 94
Buffalo 86
Bremen 81
Moscow 81
Shenyang 79
São Paulo 76
Seattle 75
Toronto 75
Nanchang 73
Woodbridge 71
Guangzhou 68
Da Nang 65
Seoul 65
Turku 62
Rome 61
Des Moines 58
Hebei 58
Houston 58
The Dalles 58
Haiphong 56
Vienna 56
Chicago 55
Kunming 55
Bologna 50
Frankfurt am Main 48
Jakarta 48
Jiaxing 48
Dong Ket 47
Tianjin 47
Orem 45
Jinan 44
Tokyo 42
Changsha 41
Atlanta 40
Brooklyn 40
London 40
Reggio Emilia 40
Brussels 36
Ferrara 33
Groningen 33
San Francisco 33
Warsaw 33
Fremont 31
Marseille 31
Pune 30
Shenzhen 30
Belo Horizonte 29
Montreal 29
Nuremberg 28
Phoenix 28
Brno 27
Stockholm 27
Amsterdam 24
Baghdad 24
Naples 24
Falls Church 23
Grafing 23
Mexico City 23
Rio de Janeiro 23
Tashkent 23
Mumbai 22
Norwalk 22
Zhengzhou 22
Konyaalti 21
Manchester 20
Denver 19
Poplar 19
Brasília 18
Chennai 18
Totale 16.573
Salva come PNG Salva come JPEG
Nome #
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 400
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays 353
Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections 352
Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration 268
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 250
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 248
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 240
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 235
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 230
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 229
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 215
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 212
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 210
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 207
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 206
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 206
Opportunity and challenges of nasal powders: Drug formulation and delivery 206
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery 206
Identifying contact-mediated, localized toxic effects of MWCNT aggregates on epithelial monolayers: A single-cell monitoring toxicity assay 205
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 198
Mechanisms of formation and disintegration of alginate beads obtained by prilling 194
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products 190
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 185
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 183
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 181
Fluorescent Multifunctional Organic Nanoparticles for Drug Delivery and Bioimaging: A Tutorial Review 179
Dynamics of water and small molecules in bioadhesive polymer films 177
MULTILAYERED PHARMACEUTICAL FORMULATION 176
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 176
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 173
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 173
Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation 172
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 171
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 170
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 170
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 168
Formulation of siRNA nanoparticles, transfection and enhanced adhesion -penetration in nasal mucosal tissue 167
Assemblage of novel release modules for the development of adaptable drug delivery systems 167
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 166
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 166
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 165
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 165
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 164
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 163
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 162
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 162
Cell penetrating peptides in ocular drug delivery: State of the art 161
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide 160
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 160
A Liposome-Micelle-Hybrid (LMH) Oral Delivery System for Poorly Water-Soluble Drugs: Enhancing Solubilisation and Intestinal Transport 160
Polysaccharides: New Frontiers for Nasal Administration of Medicines 158
Mean square hydrogen fluctuations in chitosan/lecithin nanoparticles from elastic neutron scattering experiments 157
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 157
Brain distribution of ribavirin after intranasal administration 156
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 156
Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye 155
Respicell(TM): An innovative dissolution apparatus for inhaled products 155
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 155
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 154
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 154
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 153
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 152
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 152
Flexibility and drug release features of lipid/saccharide nanoparticles 151
Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin 151
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 151
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 151
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 150
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 149
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 148
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 148
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 148
Assembled modules technology for site-specific prolonged delivery of norfloxacin 146
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 146
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 146
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 146
Les formes pharmaceutiques du futur 145
Ucuùba Fat Characterization and Use to Obtain Lipid Nanoparticles by High-Pressure Homogenization with Full Factorial Design 144
Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention 143
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 142
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 142
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 142
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 141
Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration 141
A consensus research agenda for optimising nasal drug delivery 139
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 139
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 138
Nasal delivery as a strategy for the prevention and treatment of COVID-19 137
Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering 136
Modular systems fitted together for the controlled release of substances 135
New modules, new assembly kits and new assembles for controlled release of substances 134
IN13 Backscattering Spectrometer at ILL: Looking for Motions in Macromolecules and Organisms 134
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 133
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 132
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 131
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 130
Development and validation of a RP-HPLC method for the simultaneous detection and quantification of simvastatin's isoforms and coenzyme Q10 in lecithin/chitosan nanoparticles 128
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 127
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections 127
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 126
Totale 17.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022955 0 36 19 66 45 61 98 103 50 71 55 351
2022/20233.549 367 386 220 258 287 361 37 259 1.192 31 107 44
2023/20241.636 86 129 40 62 115 359 222 126 47 100 138 212
2024/20255.143 124 256 330 395 505 635 288 207 601 475 438 889
2025/202611.204 959 877 1.326 945 1.512 555 1.189 352 1.436 932 648 473
2026/20271.532 847 685 0 0 0 0 0 0 0 0 0 0
Totale 28.929